Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Chemidox Clinical Trials (Site 0145)

Lancaster, California 93534, United StatesNot linked to an institution yet

1running trial

Running trials

Active, not recruiting
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Chemidox Clinical Trials (Site 0145): trial site – Frontlight Research